Personalized Medicine / GLP-1 Programs
GLP-1 Programs
Medical weight management, individually guided.
Physician-guided programs using compounded semaglutide or tirzepatide — as a measured microdose approach or a structured ninety-day program. An independent licensed provider determines which, if any, is appropriate for you.
View ProgramsPrograms
Four considered paths.
Microdose Semaglutide
A more measured approach.
Lower-dose semaglutide within a personalized, physician-guided program, shaped around your goals and clinical needs.
- Individualized DosingA lower-dose approach guided by your provider.
- Appetite RegulationSemaglutide acts on pathways involved in hunger and satiety.
- Clinical OversightTreatment decisions tailored to your medical profile.
Semaglutide · 90-Day Program
Weight management, thoughtfully guided.
A comprehensive ninety-day approach to medical weight management, with individualized dosing and ongoing clinical oversight.
- Established PathwayAt studied therapeutic doses, semaglutide has been shown to support meaningful weight reduction.
- Appetite ControlHelps regulate hunger and promote a feeling of fullness.
- Ninety-Day ContinuityA structured program with individualized dosing and medical guidance.
Microdose Tirzepatide
Small doses. Individual care.
A lower-dose approach to tirzepatide, with personalized medical evaluation and dosing determined by your provider.
- Dual-Pathway ActionActs on both GIP and GLP-1 receptors involved in metabolic regulation.
- Personalized DosingA lower-dose approach based on individual clinical evaluation.
- Physician-GuidedMedical oversight throughout treatment.
Tirzepatide · 90-Day Program
A dual-pathway program.
A physician-guided ninety-day program designed around your individual needs, with personalized dosing and ongoing support.
- Weight ManagementHas been shown to support clinically meaningful weight reduction at studied therapeutic doses.
- Appetite RegulationActs on hormonal pathways involved in hunger and satiety.
- Ongoing SupportA ninety-day plan with individualized medical oversight.
Program
Begin with a consultation.
Choose the program you would like to discuss. Your provider confirms whether it is appropriate and, if so, the details of your plan.
Program
- Online consultation with an independent licensed provider
- If prescribed, medication fulfilled by a licensed pharmacy
- Dosing and follow-up set by your provider
Program pricing does not guarantee a prescription; your provider decides whether treatment is appropriate.
Semaglutide and tirzepatide in these programs are compounded medications prepared by a licensed pharmacy. Compounded medications are not FDA-approved, have not been reviewed by the FDA for safety or effectiveness, and are not the same as brand-name products such as Wegovy® or Zepbound®. Microdose programs use lower doses than those studied in major clinical trials, and evidence for them is more limited. GLP-1 medications are not appropriate for everyone — including people with a personal or family history of medullary thyroid carcinoma or MEN 2 — and your provider will review your full history.
Other programs
We facilitate access to independent licensed medical providers and do not prescribe, compound or dispense medication. Eligibility, prescribing and dosing decisions are made solely by the treating provider. All treatments are subject to independent medical evaluation, provider approval and prescription when clinically appropriate. Results and eligibility vary, and some compounded medications are not FDA-approved.